Larry Robbins's THC Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 2.3M shares of Tenet Healthcare Corporation (THC) worth $471.8 M, representing 10.50% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Larry Robbins has maintained a long-term strategic position in THC, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2013, adding 3.8M shares. Largest reduction occurred in Q1 2021, reducing 4.5M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Tenet Healthcare Corporation (THC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenet Healthcare Corporation (THC) Trades by Larry Robbins
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +9.84 M | Add 0.00% | 9.84 M | $46.10 |
| Q3 2013 | +160,000 | Add 1.63% | 10 M | $41.19 |
| Q4 2013 | +3.81 M | Add 38.14% | 13.81 M | $42.12 |
| Q2 2015 | +979,482 | Add 7.09% | 14.79 M | $57.88 |
| Q3 2015 | +1.7 M | Add 11.48% | 16.49 M | $36.92 |
| Q4 2015 | +1.4 M | Add 8.49% | 17.89 M | $30.30 |
| Q4 2017 | +5,084 | Add 0.03% | 17.9 M | $15.16 |
| Q1 2019 | +5,614 | Add 0.03% | 17.9 M | $28.84 |
| Q2 2019 | +15,968 | Add 0.09% | 17.92 M | $20.66 |
| Q3 2019 | +1.56 M | Add 8.69% | 19.47 M | $22.12 |
| Q4 2019 | +261,540 | Add 1.34% | 19.74 M | $38.03 |
| Q2 2020 | +25,728 | Add 0.13% | 19.76 M | $18.11 |
| Q4 2020 | -1.5 M | Reduce 7.60% | 18.26 M | $39.93 |
| Q1 2021 | -4.53 M | Reduce 24.83% | 13.73 M | $52.00 |
| Q2 2021 | -3.08 M | Reduce 22.44% | 10.65 M | $66.99 |
| Q3 2021 | -1.99 M | Reduce 18.72% | 8.65 M | $66.44 |
| Q4 2021 | -1.33 M | Reduce 15.32% | 7.33 M | $81.69 |
| Q1 2022 | -946,065 | Reduce 12.91% | 6.38 M | $85.96 |
| Q2 2022 | +444,628 | Add 6.97% | 6.83 M | $52.56 |
| Q3 2022 | +1.27 M | Add 18.66% | 8.1 M | $51.58 |
| Q4 2022 | +796,463 | Add 9.83% | 8.9 M | $48.79 |
| Q1 2023 | -1.63 M | Reduce 18.31% | 7.27 M | $59.42 |
| Q2 2023 | -798,771 | Reduce 10.99% | 6.47 M | $81.38 |
| Q3 2023 | +396,344 | Add 6.13% | 6.87 M | $65.89 |
| Q4 2023 | +877,180 | Add 12.78% | 7.74 M | $75.57 |
| Q1 2024 | -1.42 M | Reduce 18.28% | 6.33 M | $105.11 |
| Q2 2024 | -1.66 M | Reduce 26.26% | 4.67 M | $133.03 |
| Q3 2024 | -2.01 M | Reduce 43.01% | 2.66 M | $166.20 |
| Q4 2024 | +178,294 | Add 6.71% | 2.84 M | $126.23 |
| Q1 2025 | +557,749 | Add 19.66% | 3.39 M | $134.50 |
| Q2 2025 | -464,829 | Reduce 13.69% | 2.93 M | $176.00 |
| Q3 2025 | -606,326 | Reduce 20.69% | 2.32 M | $203.04 |
Larry Robbins's Tenet Healthcare Corporation Investment FAQs
Larry Robbins first purchased Tenet Healthcare Corporation (THC) in Q2 2013, acquiring 9,839,339 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Tenet Healthcare Corporation (THC) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins's largest addition to Tenet Healthcare Corporation (THC) was in Q2 2013, adding 9,839,339 shares worth $453.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 2,323,679 shares of Tenet Healthcare Corporation (THC), valued at approximately $471.8 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Tenet Healthcare Corporation (THC) represents approximately 10.50% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins's peak holding in Tenet Healthcare Corporation (THC) was 19,761,353 shares, as reported at the end of Q2 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.